| Lubenau, Heinz (Vaximm 201101 Managing Director Vaximm GmbH before BioGeneriX before Servier) |
Managing Director |
Vaximm (Group) |
Germany |
| Lubenow, Helge (Proteomedix 202001– CEO before Consultant before 1997–2015 at Qiagen) |
Chief Executive Officer (CEO) |
Proteomedix AG |
Switzerland |
| Lubert, Wolfgang (EnjoyVenture Management GmbH 201003 Managing Director [CEO]) |
Managing Director |
EnjoyVenture (Group) |
Germany |
| Lucas, Svetlana (Tizona Therapeutics 201510 VP Business Development) |
Business Development Manager / Strategy Manager |
Tizona Therapeutics Inc. |
|
| Luchinat, Claudio (Univ Florence 201706 Professor + Co-Founder of Magnetic Resonance Center (CERM)) |
Professor |
University of Florence |
Italy |
| Lucier, Gregory T. (NuVasive 201505– CEO before CEO of Life Technologies + Invitrogen 2003–2014) |
Chief Executive Officer (CEO) |
NuVasive (Group) |
United States (USA) |
| Lucke, Marc-Olivier (Atlantic Labs Manager GmbH 201909) |
n. a. |
Atlantic Labs Manager GmbH |
Germany |
| Ludwig, Matthias (Endress+Hauser 201705 Life Science Applications Specialist at Analytik Jena) |
n. a. |
Endress+Hauser (Group) |
Germany |
| Ludwig, Petra (Technologiepark Warnemünde 201103 Managing Director) |
Managing Director |
Technologiepark Warnemünde GmbH (TPW) |
Germany |
| Lues, Inge (Probiodrug 201410–201810 Chief Developm Offficer RETIRED 10/18 before Merck KGaA 1998–2007) |
Research & Development Manager |
Vivoryon (Group) |
Germany |
| Luider, Theo (Erasmus Univ 201206 Head of Laboratories of Neuro-Oncology at Dept of Neurology at EMC) |
Laboratory Manager (university / research institute) |
Erasmus University Rotterdam |
Netherlands |
| Luly, Jay R. (Enanta Pharmaceuticals 201202 CEO) |
Chief Executive Officer (CEO) |
Enanta Pharmaceutcials Inc. |
United States (USA) |
| Lun, Klaus (Tecan 201612– promoted to Head of Life Sciences joined 201306 before Molecular Devices + Leica Microsystems) |
President/Director/Head Business Group/Unit/Division |
Tecan (Group) |
Switzerland |
| Lundberg, Bill (Merus 202001– CEO formerly CRISPR Therapeutics + Alexion + Taligen) |
Chief Executive Officer (CEO) |
Merus (Group) |
Netherlands |
| Lundberg, Jan M. (Lilly 201003– EVP Science + Technology before AstraZeneca EVP Global Discovery Research) |
Research & Development Manager |
Eli Lilly (Group) |
United States (USA) |
| Lundemose, Anker (Mission Therapeutics 201501– CEO before Bionor Pharma + OSI Pharma + Prosidion + Novo Nordisk) |
Chief Executive Officer (CEO) |
Mission Therapeutics Ltd. |
United Kingdom (GB) |
| Luo, Jiali (Boehringer 201801 General Manager of Boehringer Ingelheim Biopharmaceuticals (China) Co Ltd) |
General Manager (management) |
Boehringer Ingelheim (Group) |
China |
| Luo, Peizhi (Peter) (Adagene 201904 CEO + Founder before Abmaxis) |
Chief Executive Officer (CEO) |
Adagene (Group) |
United States (USA) |
| Luria, Xavier (AMP BIosimilars 201504 Scientific Board Member + former Head of Medicines Safety + Efficacy at EMA) |
Board member, non-executive |
AMP Biosimilars AG |
Germany |
| Luscombe, Caroline (Sanofi 201810– Head of Human Resources before LafargeHolcim + Syngenta + GE + Amersham) |
Human Resources Manager |
Sanofi (Group) [since May 2011] |
France |
| Lusser, Markus B. (Danaher 201507– President Leica Microsystems before VP Global Sales AB Sciex) |
Managing Director |
Danaher (Group) |
Germany |
| Luther, Rolf (Fuchs Petrolub 201409 Head of Advanced Development) |
Research & Development Manager |
Fuchs Petrolub (Group) |
Germany |
| Lutz, Michael (HepaRegenix 201910– Managing Director (CEO) before LifeCodexx + Clinical Data/Cogenics + Epidauros) |
Managing Director |
HepaRegenix GmbH |
Germany |
| Lutz, Phillipe (Telormedix 201005– CFO before Synosia Therapeutics CFO before Credit Suisse) |
Chief Financial Officer (CFO) |
Telormedix S.A. |
Switzerland |
| Lutz, Regina (MC Services 202209) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Lübbert, Hermann (Biofrontera 200311 CEO) |
Chief Executive Officer (CEO) |
Biofrontera (Group) |
Germany |
| Lübke, Julian (Cubuslab 201905 HeadProduct + Co-Founder) |
Product Manager (personnel) |
Labforward (Group) |
Germany |
| Lücke, Klaus (Gilupi GmbH 2006–201605 Managing Director + Founder LEFT 5/16) |
Managing Director |
Viroad (Group) |
Germany |
| Lüdke, Gerd (Curetis 201310 Director Bio-Assay Development) |
Research & Development Manager |
OpGen (Group) |
Germany |
| Lührs, Renke (Buse Heberer Fromm 201508 + DBI AG 201508 Supervisor Board Member) |
Attorney / Lawyer |
Buse Heberer Fromm Rechtsanwälte |
Germany |
| Lührs, Thorsten (SeNostic GmbH 201412– Managing Director + CO-Founder) |
Managing Director |
SeNostic GmbH |
Germany |
| Lüking, Angelika (Protagen 201009 Head R&D) |
Research & Development Manager |
Oncimmune (Group) |
Germany |
| Lynch, Carol (Novartis 201801 Global Head Biopharmaceuticals at Sandoz) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Lynch, John (Waters 201404 VP Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Waters (Group) |
United States (USA) |
| Lynch, Mike (Invoke Capital Founder) |
Chief Executive Officer (CEO) |
Invoke Capital (Myke Lynch) |
United Kingdom (GB) |
| Lüneborg, Nanna (Forbion 202109– General Partner before Novo Ventures + Apposite Capital + Cancer Research UK) |
General Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Lüninghöner, Karl-Heinz (Biofrontera 201202 Sales Manager) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Germany |
| Lyons, Shane (Danaher 201709 President of Phenomenex) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Lysikatos, Andrew (Axxin 201509 CEO) |
Chief Executive Officer (CEO) |
Axxin Pty Ltd. |
Australia |
| Lüth, Peter (Prophyta GmbH 201301 Managing Director + Co-founder) |
Managing Director |
Bayer (Group) |
Germany |
| Lüthgens, Kai-Jürgen (Cenata GmbH 201510 Managing Director) |
Managing Director |
Cenata GmbH |
Germany |
| Lüthi, Lisa (Zur Rose Group 202007 Head of Group Communications) |
Public Relations Manager / Investor Relations Manager |
Zur Rose Group (Group) |
Switzerland |
| Lütjens, Robert (Addex 201802 Head of Discovery) |
management (personnel) |
Addex (Group) |
Switzerland |
| Lütjohann, Dominic (Cubuslabs 201506– Mananaging Director + Co-Founder) |
Managing Director |
Labforward (Group) |
Germany |
| Lütolf, Michael (Verve Capital Partners 202002 investiere) |
n. a. |
Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) |
Switzerland |
| Lützeler, Claudia (Lützeler und Partner 200809 Dusseldorf) |
n. a. |
Lützeler und Partner Rechtsanwälte (Dusseldorf) |
Germany |
| Lämmerhofer, Michael (Univ Tübingen 201504 Professor) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Läubli, Markus (Metrohm 201411 Manager Marketing Support IC) |
Support Manager / Service Manager |
Metrohm (Group) |
Switzerland |
| Läufer, Albrecht (Ayoxxa 202203– CEO before Direvo + Corvay + BioRegioN Cluster Manager) |
Chief Executive Officer (CEO) |
Ayoxxa (Group) |
Germany |
| Löffert, Dirk (Qiagen 200604 Director RnD Nucleic Acid Modification + Amplification) |
Research & Development Manager |
Qiagen (Group) |
Germany |
| Löffler, M. (Uni Leipzig Institute for Medical Informatics 200606 Prof) |
Professor |
University of Leipzig |
Germany |
| Löffler, Markus |
n. a. |
University of Leipzig |
Germany |
| Lögler, Lena (Trenzyme 202010 Online Marketing Manager) |
Sales Manager / Marketing Manager |
Trenzyme (Group) |
Germany |
| Löscher, Ralf (LECO 201106 Managing Director of LECO Instrumente GmbH) |
Managing Director |
Leco (Group) |
Germany |
| Löschmann, Peter-Andreas (Pfizer 201502) |
n. a. |
Pfizer (Group) |
Germany |
| Löwe, Robert Peter Stephan (GeneWake GmbH 200910– Managing Director) |
Managing Director |
GeneSurge GmbH |
Germany |
| L’Heureux, Eric (Schott 202108– Managing Director of Schott Kaisha before Head of Operations) |
Managing Director |
Schott AG |
India |
| L’Huillier, Phil (Catalym 202105– CEO before MSD Europe + Cancer Research Technology + BioFocus Discovery) |
Chief Executive Officer (CEO) |
Catalym GmbH |
Germany |
| Ma, Philip (PrognomiQ 202009– CEO + Founder before Seer 201812 CBO + Co-Founder before Biogen + McKinsey) |
Chief Executive Officer (CEO) |
PrognomiQ Inc. |
United States (USA) |
| Maack, Kristin (Indivumed 202103 Senior Director Marketing + Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Indivumed (Group) |
Germany |
| Maas, Cornelius (SHS 201812 Senior Investment Manager) |
Investment Manager |
SHS Capital (Group) |
Germany |
| Maas, Jochen (Sanofi 201505 Managing Director RnD at Sanofi Germany) |
Research & Development Manager |
Sanofi (Group) [since May 2011] |
Germany |
| Maas, Ruth (Autodisplay Biotech GmbH 201112 Managing Director) |
Managing Director |
Autodisplay Biotech GmbH |
Germany |
| Maas, Sylke (BioNTech 202005 VP Investor Relations + Business Strategy) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Germany |
| Maas, Werner (Bruker 201104 President Bruker BioSpin) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Maass, Gerrit (Pantherna Therapeutics 202201 CFO) |
Chief Financial Officer (CFO) |
Pantherna Therapeutics GmbH |
Germany |
| Maaß, Peter (Univ Bremen 200901 Prof Zentrum für Technomathematik + SCiLS GmbH Co-Founder) |
Professor |
University of Bremen |
Germany |
| Maaß, Sebastian (Sopat GmbH 201302 Managing Director) |
Managing Director |
Iann (Group) |
Germany |
| MacCoss, Michael (Univ Washington 201209 Associate Professor + Head of MacCoss Lab of Biological Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Washington |
United States (USA) |
| Macdonald, Jamie (Parexel 201910 CEO) |
Chief Executive Officer (CEO) |
Parexel (Group) |
United States (USA) |
| MacDougall, Douglas (MacDougall Biomedical Communications 201412 President + Founder) |
President/Director/Head Business Group/Unit/Division |
MacDougall Advisors Inc. |
United States (USA) |
| Machielse, Ben (Mosanna Therapeutics 202207 Board Chair before Vtesse + Omthera Pharmaceuticals) |
Board member, non-executive |
Mosanna Therapeutics AG |
Switzerland |
| Machnig, Matthias (Germany (govt) 201504 State Secretary at BMWi) |
Governmental Officer (personnel) |
Germany (govt) |
Germany |
| Macht, Marcus (MS Vision 201703– EU Sales + Marketing Manager before AB Sciex + Bruker) |
Sales Manager / Marketing Manager |
MS Vision (Group) |
Germany |
| Macht, Martina (Bruker 201801 Head Commercial Back Office EMA at Bruker Daltonics) |
n. a. |
Bruker (Group) |
Germany |
| Maciejewski, Rob Konrad (Biolytica 202209 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Biolytica AG |
Switzerland |
| Mack, Matthias (Univ Regensburg 201207 Professor at University Hospital Regensburg Internal Medicine II) |
Professor |
University of Regensburg |
Germany |
| Mack, Mike (Syngenta – 201510 CEO before COO STEPPED DOWN 10/15) |
Chief Executive Officer (CEO) |
Syngenta (Group) |
Switzerland |
| MacKay, Charles (Pfizer 201509 CSO Inflammation + Immunology) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pfizer (Group) |
United States (USA) |
| MacKay, Gerry (Sartorius 201703– EVP Marketing + Sales + Services Lab Division joined 2015 as CEO of BioOutsource) |
Chief Commercial Officer (CCO) |
Sartorius (Group) |
Germany |
| MacLaughlin, Fiona (ABP (NL) 201902 at Inkef Capital) |
Investment Manager |
ABP (Stichting Pensioenfonds) (Group) |
Netherlands |
| MacMartin-Moglia, Kim (Inova Diagnostics 201608 Director Business Development) |
Business Development Manager / Strategy Manager |
Werfen (Group) |
United States (USA) |
| Macoun, Roman (Thermo Fisher 201410) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
Germany |
| Madaus, Martin D. (Carlyle Group 202003 Operating Executive before Ortho CDx + Quanterix + Millipore + Roche Dx NA) |
Board member |
Carlyle (Group) |
United States (USA) |
| Madigan, Sanford J. (Ankasa Regenerative 201507 CEO) |
Chief Executive Officer (CEO) |
Ankasa Regenerative Therapeutics Inc. |
United States (USA) |
| Madisch, Iljad (ResearchGATE 201705 Founder) |
Company Founder |
ResearchGate (Group) |
Germany |
| Madla, Raik (Arivis 201101 Managing Director) |
Managing Director |
Arivis – Multiple Image Tools GmbH |
Germany |
| Maelicke, Alfred (Galantos 201309 Managing Director + Founder of Galantos Pharma) |
Managing Director |
Galantos (Group) |
Germany |
| Maertens, Barbara (Cube Biotech 201212 Managing Director before Qiagen) |
Managing Director |
Cube Biotech GmbH |
Germany |
| Maertens, Geert (Biocartis 201310 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biocartis (Group) |
Belgium |
| Magadeev, July (Delrus 201205 President) |
President/Director/Head Business Group/Unit/Division |
Delrus Inc. (RU) |
Russian Federation |
| Maggos, Chris (LifeSci Advisors 201511 Managing Director Europe before Addex 201106–201302 BusDev + Communication) |
Public Relations Manager / Investor Relations Manager |
LifeSci (Group) |
United States (USA) |
| Magni, Guido (Versant Ventures 201404 Venture Partner in Basel) |
Venture Partner |
Versant Ventures |
Switzerland |
| Magnusson, Åsa (Vicore Pharma 202110– Chief Commercial Officer before Arvelle Therapeutics + Alexion + Actelion) |
Chief Commercial Officer (CCO) |
Vicore Pharma (Group) |
Sweden |
| Magovcevic-Liebisch, Ivana (Vigil Neuroscience 202012– CEO formerly Ipsen 201906 EVP + CBO) |
Chief Executive Officer (CEO) |
Vigil Neuroscience Inc. |
United States (USA) |
| Mahadevia, Ankit (Atlas Venture 201306 Venture Partner) |
Partner (venture partner) |
Atlas Venture (Group) |
United States (USA) |
| Mahaffy, Patrick J. (Clovis Oncology 200904– CEO before Pharmion CEO) |
Chief Executive Officer (CEO) |
Clovis Oncology (Group) |
United States (USA) |
| Mahdavi, Behzad (Ginkgo Bioworks 202209– SVP Biopharma Manufacturing + Life Science Tools before Catalent + Lonza) |
President/Director/Head Business Group/Unit/Division |
Ginkgo Bioworks (Group) |
United States (USA) |
| Mahieux, Patrick (Mérieux 201803 General Manager of ABL Europe) |
General Manager (management) |
Mérieux (Group) |
France |
| Mahler, Michael (Inova Diagnostics 201608 VP RnD) |
Research & Development Manager |
Werfen (Group) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 43 44 45 ... 81 82 83 
![Picture [iito] Männer Ballett 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
